TWIM
PFE icon

TIAA Wealth Investment Management’s Pfizer PFE Stock Holding History

TIAA Wealth Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Buy
45,520
+3,046
+7% +$79.7K 0.01% 184
2026
Q1 		$1.19M Buy
+42,474
New +$1.13M 0.01% 155

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TIAA Wealth Investment Management's PFE Position: Q2 2026 in Review

TIAA Wealth Investment Management increased its Pfizer (PFE) stake by 7.2% in Q2 2026, buying an estimated $79.7K and bringing the position to 45,520 shares worth $1.1M. The position accounts for 0.01% of the portfolio, ranked #184.

TIAA Wealth Investment Management first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.19M in Q1 2026. 2,713 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • TIAA Wealth Investment Management held 45,520 shares of Pfizer worth $1.1M as of Q2 2026.
  • TIAA Wealth Investment Management bought 3,046 Pfizer shares in Q2 2026, an estimated $79.7K.
  • Pfizer made up 0.01% of TIAA Wealth Investment Management's portfolio in Q2 2026, its #184 holding.
  • TIAA Wealth Investment Management first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
  • TIAA Wealth Investment Management's Pfizer position peaked at $1.19M in Q1 2026.
  • 2,713 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on TIAA Wealth Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.